PARAMEDIC2
2018
Adrenaline versus Placebo in Out-of-Hospital Cardiac Arrest
In 8,014 adults with OHCA, 1 mg intravenous adrenaline increased 30-day survival versus placebo, without improving favourable neurologic survival.
Result
Efficacy: 30-day survivalOR 1.39 · P = 0.02
Below 1 favours placebo, above 1 favours 1 mg intravenous adrenaline.
- Absolute difference
- 0.8 points
- NNT
- 125
Absolute difference and NNT are derived from the event rates.
Also reported: Favourable neurologic survival 2.2% vs 1.9% (NS).
- Subtopic
- Adrenaline
- Design
- Double-blind RCT, UK
- Relevance
- Practice-defining: a trial the guidelines cite as evidence.
- Also listed in
- Cardiac arrest & CPR
- Source
- Perkins GD, et al. N Engl J Med. 2018;379(8):711-721.doi 10.1056/NEJMoa1806842
Discussion & critique
Modest survival gain at the cost of more severe-disability survivors: central debate in resuscitation ethics.